Consolidated Statements of Income - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Sales, net	$ 52,769	$ 49,977
Cost of sales	46,042	43,755
Gross profit	6,727	6,222
Selling and administrative expenses	3,468	3,518
Operating income	3,259	2,704
Other income (expense), net:
Interest expense	(397)	(630)
Unrealized gain (loss) on investment in iBio Stock	103	(23)
Realized gains on sale of investment in iBio Stock	72
Other (expense) income, net	51	(9)
Total other expense, net	(171)	(662)
Income before income taxes	3,088	2,042
Income tax (benefit) expense, net	(1,020)	354
Net income	$ 4,108	$ 1,688
Basic net income per common share (in dollars per share)	$ 0.14	$ 0.06
Diluted net income per common share (in dollars per share)	$ 0.13	$ 0.06
Weighted average common shares outstanding - basic (in shares)	29,572,255	28,930,495
Add: Equivalent shares outstanding - stock options (in shares)	1,584,995	656,055
Weighted average common shares outstanding - diluted (in shares)	31,157,250	29,586,550